Enfortumab Vedotin
Common Brand Names:
Padcev
Drug Class
Miscellaneous antineoplastics
Animal-free Options?
Contact Pill Clarity for more information.
Indication
Used in combination with pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph, as neoadjuvant treatment and then continued after cystectomy as adjuvant treatment, is indicated for the treatment of adult patients with muscle invasive bladder cancer (MIBC) who are ineligible for cisplatin-containing chemotherapy
Why you need to contact us:
Formulations are subject to change, so it's important to consult your healthcare provider or the manufacturer. Our Pill Clarity pharmacists are here to assist. Please note that our product information is general and not a substitute for professional medical advice. Pill Clarity does not assess safety or efficacy of medications.
*The product and/or information provided on Pill Clarity is of a general nature and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. We do not lab test the products to confirm that they are free from animal ingredients, and it is possible that the formulation and ingredients could have changed. Pill Clarity does not assess safety or efficacy of medications. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or product.